2021 US Microbiology Market Assessment: Supplier Shares and Sales Segment Forecasts
This report provides an overview of the US infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.
Contains 43 pages and 9 tables
Contains 43 pages and 9 tables
BUSINESS ENVIRONMENT
1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
11. Laboratory Regulations
MARKET STRUCTURE
1. Centralized Testing
a. Hospitals
b. Commercial/Private Laboratories
c. Blood Banks
1) Community and Regional Centers
2) Plasma Fractionation Centers
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Point of Care Testing
c. Other Decentralized Testing Locations
MARKET SIZE, GROWTH, AND MAJOR SUPPLIERS’ MARKET SHARES
LIST OF TABLE
Test Volume Forecast by Market Segment
Sales Forecasts by Market Segment
LIST OF TABLE (CONTINUED)
AIDS Testing: Market Shares of Major Suppliers
Chlamydia Testing: Market Shares of Major Suppliers
Gonorrhea Testing: Market Shares of Major Suppliers
Hepatitis Testing: Market Shares of Major Suppliers
Rubella Testing: Market Shares of Major Suppliers
Streptococci Testing: Market Shares of Major Suppliers
Syphilis Testing: Market Shares of Major Suppliers
1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
11. Laboratory Regulations
MARKET STRUCTURE
1. Centralized Testing
a. Hospitals
b. Commercial/Private Laboratories
c. Blood Banks
1) Community and Regional Centers
2) Plasma Fractionation Centers
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Point of Care Testing
c. Other Decentralized Testing Locations
MARKET SIZE, GROWTH, AND MAJOR SUPPLIERS’ MARKET SHARES
LIST OF TABLE
Test Volume Forecast by Market Segment
Sales Forecasts by Market Segment
LIST OF TABLE (CONTINUED)
AIDS Testing: Market Shares of Major Suppliers
Chlamydia Testing: Market Shares of Major Suppliers
Gonorrhea Testing: Market Shares of Major Suppliers
Hepatitis Testing: Market Shares of Major Suppliers
Rubella Testing: Market Shares of Major Suppliers
Streptococci Testing: Market Shares of Major Suppliers
Syphilis Testing: Market Shares of Major Suppliers
More Publications
US Hepatitis Market 2019-2023: Supplier Shares and Sales Forecasts for 10 Immunodiagnostic and NAT Procedures-Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices
US$ 3,900.00
April 2019
241 pages
US Microbiology Analyzers and Consumables: Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
US$ 7,880.00
June 2016
436 pages
2017 US Clinical Chemistry and Immunodiagnostics Market Future Horizons and Growth Strategies: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities
US$ 10,350.00
March 2017
600 pages
The US AIDS Testing Market 2015 (DataPack)
US$ 720.00
May 2015
-
2013 US Flow Cytometry Market: Opportunities and Strategies for Suppliers
US$ 4,720.00
December 2012
174 pages